MMS vs DLB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MMS · Maximus$62.79 ▲ 1.27%
DLB · Dolby Laboratories$55.33 ▲ 1.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MMS -25.1%
- DLB -2.5%
Head to head
| Metric | MMS | DLB |
|---|---|---|
| Price | $62.79 | $55.33 |
| Change today | ▲ 1.27% | ▲ 1.02% |
| Market cap | $3.30B | $5.13B |
| Return, 3 months | +15.4% | -16.2% |
| Return, year to date | -26.1% | -12.3% |
| Return, 1 year | -20.1% | -16.1% |
| P/E (TTM) | 8.6 | 20.5 |
| P/B | 1.8 | 2.0 |
| P/E percentile vs own 5y | 10th | 25th |
| Dividend yield | 2.05% | 2.60% |
| Revenue growth (YoY, latest qtr) | -5.1% | -3.3% |
| Net profit growth (YoY) | -2.3% | -37.2% |
| Gross margin | 25.6% | 87.6% |
| Operating margin | 11.0% | 19.3% |
| Net margin | 7.1% | 16.7% |
| Return on equity | 21.1% | 8.7% |
| Analyst target vs. price | – | +58.1% |
| Analyst buy share | – | 100% |
| RSI (14) | 56 | 27 |
| 30-day volatility | 35.9% | 30.1% |
| Max drawdown, 1 year | -46.5% | -29.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DLB is the largest of the group by market value.
- DLB has returned the most over the past year.
- MMS carries the lowest trailing P/E.
- DLB pays the highest dividend yield.
- DLB is growing revenue fastest.
- DLB keeps the most profit per dollar of sales.
- DLB has been the calmest stock over the last 30 days.